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ORIGINAL RESEARCH
Abstract: The pathogenesis that is primarily responsible for Alzheimer’s disease (AD) and 
cerebrovascular accidents (CVA) appears to involve chronic hypoperfusion. We studied the 
ultrastructural features of vascular lesions and mitochondria in brain vascular wall cells from 
human AD biopsy samples and two transgenic mouse models of AD, yeast artiﬁ  cial chro-
mosome (YAC) and C57B6/SJL Tg (+), which overexpress human amyloid beta precursor 
protein (AβPP). In situ hybridization using probes for normal and 5 kb deleted human and 
mouse mitochondrial DNA (mtDNA) was performed along with immunocytochemistry using 
antibodies against the Aβ peptide processed from AβPP, 8-hydroxy-2’-guanosine (8OHG), and 
cytochrome c oxidase (COX). More amyloid deposition, oxidative stress markers as well as 
mitochondrial DNA deletions and structural abnormalities were present in the vascular walls 
of the human AD samples and the AβPP-YAC and C57B6/SJL Tg (+) transgenic mice com-
pared to age-matched controls. Ultrastructural damage in perivascular cells highly correlated 
with endothelial lesions in all samples. Therefore, pharmacological interventions, directed at 
correcting the chronic hypoperfusion state, may change the natural course of the development 
of dementing neurodegeneration.
Keywords: atherosclerosis, Alzheimer’s disease, transgenic animals, brain hypoperfusion, 
vascular and mitochondrial lesions, electron microscopy
Introduction
Vascular endothelial cells, neurons and glia are all able to synthesize, store and release 
reactive oxygen species (ROS) and vasoactive substances in response to certain 
stimuli, especially those produced by chronic hypoxia/hypoperfusion (for review 
see Aliev et al 2003b). The contribution of these substances to the pathophysiology 
of stroke, cerebrovascular disease or CVAs and AD is extremely important. It has 
been suggested that hypoperfusion can be an initiator of AD (Aliev et al 2002b, 
2003a, 2003b, 2007; de la Torre 2002a). This idea is based on a positive correlation 
between AD and cardiovascular diseases. ROS are generated at sites of injury and/or 
inﬂ  ammation. We hypothesize that the cellular and molecular mechanisms, by which 
hypoperfusion-induced ROS-accumulation impairs endothelial barrier function and 
promotes leukocyte adhesion, induce alterations in normal vascular function and result 
in the development of AD (Aliev et al 2003b).
Sustained hypoperfusion promoting oxidative stress of brain tissues could also 
stimulate secondary damage via the overexpression of inducible and neuronal spe-
ciﬁ  c nitric oxide synthase (iNOS and nNOS, respectively) and endothelin-1 (ET-1) 
in brain cells (Aliev et al 2000; de la Torre 2002a; Aliyev et al 2004; de la Torre 
and Aliev 2005). The continuous accumulation of oxidative stress products, such as 
peroxynitrite accumulation (via the overexpression of the iNOS and/or nNOS), may 
be secondary as well as an accelerating factor for the damage and compromise of the Vascular Health and Risk Management 2008:4(3) 722
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blood brain barrier (BBB) in hypoxia/hypoperfusion or AD 
(Aliyev et al 2004).
One of the main effects of chronic hypoperfusion induced 
vascular abnormality in AD appears to be tissue oxygen 
deﬁ  ciency. Chronic cerebral hypoperfusion induces reduc-
tion of tissue oxygen delivery that causes the development 
of cognitive impairments such as AD (Kumar et al 1990; 
Friston and Frackowiak 1991; De Jong et al 1997; de la Torre 
1997, 2002a; Aliev et al 2007). De la Torre (2000) proposes 
that advanced aging with a comorbid condition, such as a 
vascular risk factor that further decreases cerebral perfusion, 
promotes a critically attained threshold of cerebral hypoper-
fusion (CATCH). With time, CATCH induces brain capillary 
degeneration and suboptimal delivery of energy substrates 
to neuronal tissue (de la Torre 2000). Because glucose is the 
main fuel of brain cells, its impaired delivery together with a 
deﬁ  cient delivery of oxygen, compromises neuronal stability 
because the supplies for aerobic glycolysis fail to meet the 
brain tissue demand. The outcome of CATCH is a metabolic 
cascade that involves, among other things, mitochondrial dys-
function, oxidative stress, decreased adenosine triphosphate 
(ATP) production and increased calcium entry, abnormal 
protein synthesis, cell ionic pump deﬁ  ciency, signal trans-
duction defects, and neurotransmission failure. These events 
contribute to the progressive cognitive decline characteristic 
of patients with AD, as well as regional anatomic pathology 
consisting of synaptic loss, senile plaques (SP), neuroﬁ  bril-
lary tangles (NFT), tissue atrophy, and neurodegeneration. 
CATCH encompasses the clinical heterogenic pattern that 
characterizes AD and provides compelling evidence that any 
of a multitude of different etiopathophysiologic vascular 
risk factors, in the presence of advanced aging, can lead to 
AD (de la Torre 2000, 2002b; de la Torre and Aliev 2005; 
Aliev et al 2007).
The aim of the present study was to investigate the fea-
tures of the vascular lesions in human AD and two transgenic 
mouse models of AD, lines overexpressing a mutated form 
of the amyloid beta precursor protein (AβPP). We compared 
the ultrastructural features of each and identiﬁ  ed common 
changes relative to age-matched controls that may give 
clues to underlying mechanisms affecting brain neuronal 
function.
Materials and methods
All experimental procedures were performed in accordance 
with University of Texas San Antonio and Case West-
ern Reserve University guidelines for the use of human 
biopsy and post-mortem tissues and the care and use of 
laboratory animals for research. Human AD brain biopsy 
and postmortem tissues for ultrastructural studies were taken 
as described earlier and processed for future electron micro-
scopic (EM) and in situ hybridization studies (Hirai et al 
2001; Aliev et al 2002a, 2002b, 2003a, 2007). Mouse brain 
samples were obtained from a normal, nontransgenic line 
(Py8.9-Hemi [wild type]) and 2 transgenic lines, AβPP-YAC 
and C57B6/SJL Tg (+), were obtained from Bruce Lamb and 
colleagues (1999). Animals were 22–26 months old (n = 6 
for each group). All animals received a standard laboratory 
diet ad libitum. Mice, under terminal anesthesia were perfusion 
ﬁ  xed via the heart as described previously (Aliev et al 2002a, 
2003a; Aliyev et al 2005). Brain samples were processed for 
future analysis by electron microscope and in situ hybrid-
ization for cytological detection of mtDNA on the electron 
microscopic level. In situ hybridization was performed using 
wild type and ∆5kb deleted human and mouse speciﬁ  c probes 
as described recently (Aliev et al 2003a; Aliev 2007). Finally, 
all the sections were exposed to OsO4 for 1 h at RT, rinsed, 
dehydrated and ﬂ  at embedded in Spurr’s embedding media. 
Ultrathin sections were stained with uranylacetate and lead 
citrate and viewed in a JEOL 100CX or Jeol 1230 EX electron 
microscope at 80 kV.
Results and discussion
Endothelial cells (EC) and perivascular cells of human brain 
microvessels from age-matched control cases showed no 
visible changes in their ultrastructure. Mitochondria in the 
EC were intact (data not shown).
Conversely, cortical microvessels from AD brain biopsies 
were characterized by different degrees of damage, and het-
erogeneous lesions (Figures 1A–C). In some areas microves-
sels showed multiple lesions such as the presence of a cluster 
of mitochondria-derived lysosomes and necrotic changes in 
the ultrastructure of the vascular EC and perivascular cells 
(Figures 1A–B). Very often capillary endothelium cells 
showed the presence of “giant” sized lipid vacuoles in their 
matrices. Transformation of the mitochondria to mitochon-
dria-derived lysosomes was generalized to all brain cellular 
compartments (Figures 1B–C). In addition, EC occupied only 
a small part of the vessel wall. Perivascular cells showed 
the presence of a large number of the mitochondria-derived 
vacuoles in their matrices (Figure 1C). Sometimes microvas-
cular endothelium, at the early stages of AD, did not show 
any damage in their ultrastructure. However, the luminal 
plasma membrane of this EC sharply protruded into the 
vessel lumen, indicating the effect of hypoperfusion before 
any visible ultrastructural damage (Figure 1A).Vascular Health and Risk Management 2008:4(3) 723
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The ultrastructural features of vascular lesions and 
mitochondria changes in neuronal cell bodies in transgenic 
and non-transgenic age-matched control mice were analyzed 
following perfusion ﬁ  xation (Aliev et al 2000, 2003a, 2005). 
Ultrastructural changes in the brain samples of AβPP-YAC, 
but not age-matched control mice, coexisted with differ-
ent degrees of amyloid deposition (Aliev 2002; Aliev et al 
2002a).
Very often, clusters of Aβ positive immunoreactivity 
were observed in the neuronal cell bodies of perivascular 
paired cortical neurons (Aliev et al 2000; Aliev 2002). EM 
immunocytochemistry revealed different sizes of ﬁ  brils and 
extracellular types of amyloid deposits in the brain tissues 
(Figure 2A–F). The amyloid depositions were associated with 
the formation of parietal helical ﬁ  lamental (PHF) structures 
(Figure 2D–F), which is a permanent feature of neuronal 
lesions in AD brains (Aliev et al 2000, 2003a).
Brain microvessels showed immunopositive staining for 
Aβ and were characterized by the presence of large-sized 
lipid-laden vacuoles in the matrices of EC and perivascu-
lar cells (Figure 3A–D). These changes were generalized 
to cortical microvessels as in AD samples (Aliev 2002). 
The ultrastructural abnormalities of vascular wall cells 
were dependent on the presence of Aβ deposits around the 
microvessels (Figures 3–4). In contrast with these observa-
tions, age-matched control mouse brain vessels did not show 
any particular changes in the ultrastructure of vascular EC at 
different levels of microcirculation. Only sometimes did a 
very small number of lipid droplets appear in the matrices of 
perivascular cells (Aliev 2002; Aliev et al 2003a). This data 
clearly indicates that disruption of BBB function in vascular 
EC may be a major factor in lipid accumulation and amyloid 
deposition during the development of AD-like pathology in 
AβPP-YAC mice without cholesterol feeding (Aliev 2002; 
Shi et al 2002b; Aliev et al 2003a).
Ultrastructural immunocytochemical analyses using 
peroxidase-anti-peroxidase (PAP) and/or colloidal gold probes 
indicated that the damaged vascular walls in AβPP-YAC 
transgenic mice possess atherosclerotic lesions (Figure 4A–B), 
while control and non-damaged vessels from AβPP-YAC mice 
do not show Aβ immunopositive staining (data not shown).
Age-matched control mice showed no particular changes 
in their neuronal ultrastructure (Figure 5A–B). Cortical 
neuronal cell bodies in AβPP-YAC mice were characterized 
by different degrees of ultrastructural alterations in their 
mitochondrial structures (Figure 6A–F) similar to human 
AD samples (Aliev et al 1999, 2000). Giant and electron- 
dense (ED) mitochondria appeared to be permanent features 
Figure 1 Ultrastructural characteristics of brain microvessels from human Alzheimer 
disease brain biopsies. A: Microvessels with minimal changes did not show any 
particular pathology in the ultrastructure of the vascular endothelium; however, 
perivascular cells show the presence of vacuolar degenerative structures in the matrix 
(indicated by single arrow). B: Vascular endothelium and perivascular cells of damaged 
microvessels display ultrastructural lesions in their cytoplasmic organelles especially 
mitochondria. Completely damaged matrices appeared to be permanent features of 
all of these cells (indicated by single arrow). Original magniﬁ  cation ×20,000 (A and 
B). C: Vascular endothelium with non-reversible damage have completely damaged 
mitochondria and destructive changes in the membranous structures. The basal 
membrane (BM) is very thick and occupies a large area of the vascular wall. Original 
magniﬁ  cation ×12,000.Vascular Health and Risk Management 2008:4(3) 724
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of the neuronal abnormality and was associated with the 
AβPP overexpression (Aliev et al 2000, 2003a). We also 
found that mitochondrial lesions in neuronal cell bodies 
appeared to be associated with the absence of microtubules 
and with lipofuscin formation. The same observations were 
seen in the populations of vulnerable neurons in AD brain 
biopsies indicating neuronal cytoskeletal abnormalities (Cash 
et al 2003).
We looked at ultrastructural features of brain tissue from 
C57B6/SJL Tg (+) transgenic mice overexpressing AβPP. 
We demonstrated that the binding of basic ﬁ  broblast growth 
factor (bFGF) and serum amyloid P (SAP) to Aβ is a marker 
of a lack of BBB integrity in this mouse model. Adjacent 
sections of brain were stained with 4G8, a monoclonal 
antibody to the Aβ peptide (aa17–24), followed by 48.1, a 
monoclonal antibody against bFGF. The binding of bFGF 
in this mouse line is similar to that of AD cases in which 
bFGF binds speciﬁ  cally to Aβ neuritic plaques and the 
basement membrane of cerebral microvessels (Shi et al 
1999, 2002a). In addition, the cores of amyloid plaques 
were intensely stained with 4G8, and bFGF binding is 
co-localized with amyloid immunoreactivity as visualized 
by polyclonal antiserum to amyloid. Our ultrastructural 
study indicated that bFGF immunostaining in aged C57B6/
SJL Tg (+) mice was associated with damaged, but not 
normal neurons (Aliev et al 2000, 2002a, 2003a, 2007). 
Moreover, this was associated with different degrees of Aβ 
immunostaining in the neuronal cell body and vascular wall 
cells (Aliev 2002; Aliev et al 2003a; Aliyev et al 2005). 
The degree of mitochondrial abnormality, such as ED 
mitochondria-derived lysosomes and lipofuscin formation 
appeared to be features of damaged neurons in 24-month 
old aged C57B6/SJL Tg (+) but not age-matched control 
mice (Figure 7A–D). Vascular abnormality was associated 
with the selective damage to cortical neurons suggesting 
a direct relationship between vascular abnormality, BBB 
breakdown, neuronal loss and amyloid depositions during 
the maturation of AD-like pathology (Aliev 2002; Aliev 
et al 2003a).
Previously we demonstrated that the ultrastructural 
features of cortical neurons from AD brain biopsies are 
characterized by the selective localization of mitochondria 
abnormalities to the cell bodies (Aliev et al 1999, 2000; Hirai 
et al 2001; Aliev 2002; Shi et al 2002b). The majority of the 
neurons, which were closely associated with lesioned vessels, 
possessed different degrees of ultrastructural abnormality. 
Partially and completely damaged mitochondria were associ-
ated with lipofuscin formation and mitochondria appeared to 
be a major substrate for this process (Figures 6–7). In many 
cases, neuronal cell bodies showed an absence of cellular 
Figure 2 Features of amyloid deposition in a neuronal cell body and the extracellular 
matrix in AβPP-YAC aged transgenic mouse brain (PAP pre-embedding immunocy-
tochemistry). Amyloid depositions are associated with the formation of PHF-like 
structures (double asterisk in ﬁ  gure E). Original magniﬁ  cation A–D ×20,000. E–F 
× 25,000.
Figure 3 Features of APP immunostaining in frontal cortical microvessels in aged 
AβPP-YAC mice determined by PAP pre-embedding immunocytochemistry. A, B and 
C are without counter staining. D is with counter staining.   Asterisks indicate amyloid 
deposition. Original magniﬁ  cation ×12,000.Vascular Health and Risk Management 2008:4(3) 725
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organelles. Different stages of mitochondrial abnormality, 
such as formation of mitochondria-derived lysosomes and 
lipofuscin, were seen in damaged but not in normal neu-
rons (Figures 6–7). The mitochondria-derived lysosomes 
and lipofuscin deposits of varied density and sizes were 
permanent features of the neuronal abnormality (Aliev et al 
2003a). Mitochondrial lesions and lipofuscinogenesis were 
also present in glial cells of the brain parenchyma (Aliev 
et al 2003a).
Quantitative morphometric measurements of the percent-
age of the different types of mitochondria (normal, partially 
damaged, and completely damaged) indicate that age-
matched control groups have a signiﬁ  cantly higher percent-
age of normal mitochondria compared with AD cases (Hirai 
et al 2001). Cytological in situ hybridization studies using 
probes for human normal and 5 kB deleted mtDNA found 
that mtDNA signals were associated with severely damaged 
or mitochondria-derived lysosomal structures (Figure 8). 
However, the areas containing lipofuscin did not show any 
mtDNA containing positive signals. On the ultrastructural 
level, clusters of 5 kb deleted mtDNA containing gold 
particles (17 nm) were localized in mitochondria-derived 
lysosomal structures, indicating that mtDNA deletions 
and turnover occur at the late stages of the mitochondrial 
lesion formation. Similarly, areas of neuronal cell bodies 
containing normal mtDNA and lipofuscin were free from any 
5 kb deleted mtDNA positive signals (Hirai et al 2001; Aliev 
et al 2002a). In contrast to this observation, hippocampal 
neuronal mitochondria of age-matched control subjects did 
not show mtDNA positive signals containing gold particles 
in their matrices.
Our detailed immunocytochemical analysis also 
demonstrated that the mitochondrial abnormalities in neurons 
are associated with increased markers of lipid peroxidation 
(Moreira et al 2007). Moreover, lipid peroxidation markers 
were associated with RNA oxidation (staining by 8OHG). 
Clusters of 8OHG containing immunopositive gold particles 
(17 nm) were localized to the matrices of completely and/or 
partially damaged mitochondria (Nunomura et al 2001; Aliev 
et al 2002, 2002a). Large quantities of immunopositive gold 
particles were also associated with the cytoplasmic matrix. In 
addition, the cytoplasmic matrices, especially of the regions 
where damaged mitochondria or mitochondria-lipofuscin were 
present, showed clusters of 8OHG containing immunopositive 
gold particles (Aliev et al 2002, 2002a). Our quantitative study 
indicated that the extent of oxidative damage (eg, 8OHG 
staining) is highly dependent on the degree of mitochondrial 
abnormalities (Nunomura et al 2001; Aliev et al 2003a). 
Figure 5 Age-matched control, non-transgenic mice did not show any particular 
changes in their neuronal ultrastructure. Lipofuscin was present in some neurons 
(indicate by asterisk in ﬁ  gure A). Original magniﬁ  cation of A and B: × 5,000, and 
×20,000, respectively.
Figure 4 Electron microscopic subcellular features of brain cortical microvessels 
from 24-month old AβPP-YAC mice. A:   Vascular endothelial cells display lipid vacu-
oles in their cytoplasmic matrices (single arrow). Perivascular cells have “giant”- sized 
lipid/amyloid granules in their cytoplasmic matrices (indicated by asterisk). Original 
magniﬁ  cation: ×12,000. B: Microvessels with amyloid “angiopathy” are characterized by 
the accumulation of large-sized amyloid/lipid granules in the matrices of perivascular 
cells (indicated by asterisk). Vacuolar structures with lipid ﬁ  lled amyloid deposition 
(single arrow) are also present in the matrices of perivascular cells. Original magni-
ﬁ  cation: ×12,000.Vascular Health and Risk Management 2008:4(3) 726
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Based on the evidence presented in this study we theorize 
the hypothetical timeline of the damage in the brain during 
maturation of AD is much more complex than the previously 
proposed hypothetical schematic (Aliev et al 2003b). With 
the onset of AD, normal neurons develop numerous forms 
of oxidative damage including nitration (nitrotyrosine), 
lipid peroxide adducts (lipid peroxidation), and nucleic acid 
oxidation prior to the formation of pre-neuroﬁ  brillary tangles 
(pre-NFT) that induce nonreversible damage to neurons and 
therefore ﬁ  nally failure of neurotransmission that occurs in 
AD brain.
The detailed analysis of 8OHG immunostaining demon-
strated that only vulnerable neurons show immunopositive 
staining for 8OHG in AD, but not in age-matched controls. 
By using ultrastructural analysis we have found that 8OHG 
immunostaining was selectively associated in vulnerable 
neurons and microvessels of AD brain (Aliev et al 2002b; 
Aliyev et al 2005). The 8OHG immunogold labeling (17 nm) 
was seen throughout the cytoplasm, including the damaged 
mitochondria or electron dense abnormal mitochondria (Hirai 
et al 2001; Nunomura et al 2001; Aliev et al 2002b; Moreira 
et al 2007). However, we did not ﬁ  nd 8OHG in normal mito-
chondria or in lipofuscin. The capillary EC and perivascular 
pericytes showed a high intensity of 8OHG immunostaining 
(Aliev et al 2002b).
In this study, the main location of the mtDNA was in 
damaged mitochondria and mitochondria derived lysosomes, 
but not in lipofuscin in all brain cellular compartments 
including the vascular wall cells (Figure 8A–B). Endothelial 
cells (EC) of vessels with atherosclerotic lesions and nearby 
perivascular cells contain clusters of normal and deleted 
mtDNA positive signals (Figure 8A–B). These observations 
emphasize the key role of hypoperfusion, mitochondrial 
abnormality and oxidative stress in the pathogenesis of vas-
cular and nonvascular cells lesions during the development 
of AD-like pathology in AβPP-YAC mice (Aliev et al 2002a; 
Aliyev et al 2005). Many of these characteristics overlap the 
neuropathology of human AD (Aliev et al 2002a).
In situ hybridization analysis with mouse mtDNA 
probes found abundant deleted mtDNA in AβPP-YAC mice 
compared to age-matched controls (Aliev et al 2000, 2002a, 
2003a). Moreover, the majority of deleted mtDNA was 
found in mitochondria-derived lysosomes (Figure 8C–D) 
in regions closely associated with lipofuscin, suggesting 
that proliferation, deletion and duplication of mtDNA 
occur in mitochondria, many of which have been fused 
with lysosomes (Aliev et al 2000). These ﬁ  nding suggest 
that abnormalities in mitochondrial structures and mtDNA 
are features of damaged neurons in AβPP-YAC mice, and 
may also play a key role in the pathogenesis of AD (Aliev 
et al 2000). We found that neurons in AD samples were 
dominated by abnormal mitochondria as compared with the 
control group (Aliyev et al 2005). By in situ hybridization 
analyses with a chimeric cDNA probe to the 5 kb common 
deletion (Hirai et al 2001), we found that deleted mtDNA 
is increased at least 3 fold for the AD cases compared 
to the controls (Hirai et al 2001). In situ hybridization 
detected mtDNA proliferation, deletion and duplication in 
abnormal mitochondria, many of which were fused with 
lysosomes, indicating they were being turned over (see 
Figure 8A–B).
A growing body of evidence suggests that there are direct 
links between heart disease, hypertension, stroke and neu-
rodegeneration (Roher et al 2003; de la Torre 2006; Skoog 
and Gustafson 2006). The relationship between atheroscle-
rosis, vascular amyloidosis and brain hypoperfusion in the 
pathogenesis of sporadic Alzheimer’s disease has been well 
Figure 6 Ultrastructural characteristics of the neuronal damage in AβPP-YAC 
transgenic mouse hippocampus. Mitochondrial lesions were associated with lipofuscin 
formation in the neuronal cell body (asterisk) and mitochondria appeared to be a 
major substrate for lipofuscin formation (single arrows). Original magniﬁ  cation: A, E, 
and F × 5,000. B, C, and D × 20,000 respectively.Vascular Health and Risk Management 2008:4(3) 727
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documented (Roher et al 2003; Kalback et al 2004). Hyper-
tension has been suggested to be an initiator of the ischemic 
pathway leading to AD (Aliev et al 2003, 2007; de la Torre 
2006; Skoog et al 2006). Recently, studies by Choi and col-
leagues (2007) showed that preconditioning with chronic 
cerebral hypoperfusion reduces a focal cerebral ischemic 
injury and increases apurinic/apyrimidinic endonuclease/
redox factor-1 and matrix metalloproteinase-2 expression. 
Another report by Annaházi and colleagues (2007) demon-
strated that the pre- and post-treatment with alpha-tocopherol 
Figure 7 Ultrastructural characteristics of cortical neurons in C57B6/SJL transgenic mouse (Tg +) brain. The main characteristic of neuronal damage appeared to be the 
transformation of completely damaged mitochondria (mitochondria without any residues of mitochondrial cristae; indicated by single arrows) into the lipofuscin granules, 
characterised by their cluster type localization in the neuronal cell body. Original magniﬁ  cation: A and B ×5,000; C and D ×20,000, respectively.Vascular Health and Risk Management 2008:4(3) 728
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attenuates hippocampal neuronal damage in experimental 
cerebral hypoperfusion. Moreover, circulating CD34 posi-
tive T-cells are able to provide an index of cerebrovascular 
function (Taguchi et al 2004). The beneﬁ  cial effect of carotid 
endarterectomy on the cerebral blood ﬂ  ow and cerebral blood 
volume improvement was studied by SPECT (Lushmanov 
et al 1997).
Based on this literature evidence and our present study we 
believed that managing AD as a vascular disease will open a 
new window of insight not only for better understanding of 
Figure 8 Electron microscopic determination of mitochondrial DNA signals visualized by using wild type and chimeric 5 kb deleted mtDNA probes in a human postmortem 
Alzheimer’s disease (AD) brain (A–B) and 24-month old AβPP-YAC transgenic mouse brain (C–D). A and B: AD brain microvessels endothelium and perivascular cells show 
clusters of wild type mtDNA containing positive signals visualized by indirect colloidal gold techniques (indicated by the dark dots). Original magniﬁ  cation: A and B ×10,000 
and ×25,000, respectively. C–D: AβPP-YAC transgenic mice show the presence of clusters of chimeric 5 kb deleted mitochondria DNA positive signals throughout the matrices 
of vascular and perivascular cells (single arrows). Original magniﬁ  cation: C and D ×30,000 and ×20,000, respectively.
Abbreviations: BM, basal membrane; EC, endothelial cell; ER, erythrocytes; N, cell nucleus; VL, vessel lumen; PAP, peroxidase-anti-peroxidase; PHF, paired helical ﬁ  laments.Vascular Health and Risk Management 2008:4(3) 729
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the etiopathogenesis but also new and more effective treat-
ment strategies.
We theorize that the oxidative stress markers seen in the 
human AD and AD mouse models selectively affect the pop-
ulation of vulnerable neurons, vascular EC and perivascular 
cells. We believe that hypoperfusion-induced oxidative 
stress plays a key role in the pathogenesis of vascular and 
nonvascular cell lesions during the maturation of AD.
Conclusion
Our data for the ﬁ  rst time demonstrates that a chronic injury 
stimulus induces the hypoperfusion seen in the micro-
circulation of vulnerable brain regions. Determining the 
mechanisms behind these imbalances may provide crucial 
information in the development of new, more effective 
therapies for the treatment of cerebrovascular diseases, 
including AD. Future studies must seek to answer the fol-
lowing questions: (1) What are the major factors altering 
and/or controlling cerebral blood ﬂ  ow during the progres-
sion of chronic hypoperfusion and/or the development of 
atherosclerotic changes in brain microvessels? (2) What 
are the roles of endothelial content vasoactive substances 
(especially nitric oxide [NO] and endothelin-1 [ET-1]) dur-
ing the development of this pathophysiology? (3) Does acute 
or chronic hypoperfusion with concomitant oxidative stress 
accelerate the vascular and neuronal lesions during normal 
aging and/or when brain is exposed to chronic hypoperfusion 
induced factors? Resolving these issues will allow for novel 
therapeutic approaches that will modify the natural history 
of these chronic age onset disorders in the 21st century.
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